{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-001885","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2023-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.675753+00:00","generated_at":"2026-06-20T09:00:27.627674+00:00","sec_items":["1.01","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Windtree Therapeutics amends warrants to $0.20/sh, raises ~$1M, issues 9.6M new warrants","bullets":["Existing warrants for 4,808,595 shares exercised at reduced price of $0.20, gross proceeds ~$1.0M.","Company issued new warrants to purchase up to 9,617,190 shares at $0.2152, exercisable after 6 months.","New warrants expire 5 years from initial exercise date; beneficial ownership limit 4.99% (up to 9.99% opt-in).","Ladenburg Thalmann served as placement agent, receiving 8% fee plus 1% management fee.","Registration statement for resale of new warrant shares to be filed within 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-001885","json":"https://secwatch.observer/filing/0001437749-23-001885.json","markdown":"https://secwatch.observer/filing/0001437749-23-001885.md","text":"https://secwatch.observer/filing/0001437749-23-001885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/0001437749-23-001885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/wint20230126_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:00:27.627674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4545dffe68b099eca3ad316d5a27a9f405c1ea41","claim":"WINDTREE THERAPEUTICS INC /DE/ entered into Inducement Letters with certain holders of Existing Warrants valued at aggregate gross proceeds of approximately $1.0 million (effective 2023-01-20).","evidence_excerpt":"On January 20, 2023, Windtree Therapeutics, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with certain holders (the “Exercising Holders”) of certain of the Company’s: (i) warrants issued in December 2019 to purchase 78,643 shares of common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/0001437749-23-001885-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain holders of Existing Warrants"},{"label":"Value","value":"aggregate gross proceeds of approximately $1.0 million"},{"label":"Effective","value":"2023-01-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}